Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

    Clinical Cancer Research, Vol. 30, Núm. 5, pp. 975-983

  2. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era

    Current Opinion in Obstetrics and Gynecology, Vol. 36, Núm. 2, pp. 104-111

2023

  1. Advances in immunotherapy for cervical cancer

    Therapeutic Advances in Medical Oncology, Vol. 15

  2. Advances in immunotherapy in cervical cancer

    International Journal of Gynecological Cancer, Vol. 33, Núm. 3, pp. 403-413

2022

  1. ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation

    International Journal of Gynecological Cancer, Vol. 32, Núm. 9, pp. 1196-1200

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Treatment strategies in cervical cancer: treatment of advanced disease

    Journal of Cancer Metastasis and Treatment, Vol. 8

2015

  1. Inter-laboratory evaluation of instrument platforms and experimental workflows for quantitative accuracy and reproducibility assessment

    EuPA Open Proteomics, Vol. 8, pp. 6-15